Quantcast

Latest Natalizumab Stories

ed111cc5532039c770c314485c9b9b5a1
2009-08-18 14:51:17

Scientists believe they have discovered a link between high blood pressure and multiple sclerosis. Writing in the Proceedings of the National Academy of Sciences, neurology professor Lawrence Steinman of the Stanford University School of Medicine, said that the findings could prove that the inexpensive blood pressure drug lisinopril could be used to treat multiple sclerosis as well. Lisinopril is marketed by pharmaceutical company Merck under the name Prinivil. Steinman's team studied the...

2009-07-27 16:00:00

INDIANAPOLIS and EDMONTON, Alberta, July 27 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and BioMS Medical Corp. (TSX: MS) today announced that dirucotide did not meet the primary endpoint of delaying disease progression, as measured by the Expanded Disability Status Scale (EDSS), during the two-year MAESTRO-01 Phase III trial in patients with secondary progressive multiple sclerosis (SPMS). In addition, there were no statistically significant differences between dirucotide...

2009-06-02 10:47:27

Monoclonal antibodies can be safely and successfully used for the treatment of several gastroenterological disorders according to data being presented at Digestive Disease Week® (DDW®) 2009. DDW is the largest international gathering of physicians and researchers in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. "The use of monoclonal antibodies is rising for a number of gastroenterological disorders, such as...

2009-06-01 08:08:00

Cimzia(R) shows duration of response up to week 26 in moderate to severe Crohn's patients who failed the intravenous infusion treatment infliximab. CHICAGO, June 1 /PRNewswire/ -- New data from the WELCOME study presented by UCB at the Digestive Disease Week meeting demonstrate that Cimzia(R) (certolizumab pegol) provides sustained symptom improvement with stable dosing through week 26 for adult patients suffering from moderate to severe Crohn's disease (CD) who are intolerant or no longer...

2009-05-27 15:51:57

U.S. medical researchers say they've found a drug used to treat diabetes shows protective effects in the brains of some multiple sclerosis patients. Researchers at the University of Illinois-Chicago College of Medicine say they conducted a small, double-blind clinical trial involving patients with relapsing remitting multiple sclerosis. The patients were assigned to take pioglitazone -- a type 2 diabetes drug commercially known as Actos -- or a placebo. Patients continued their normal course...

2009-05-18 15:44:31

The 57-year-old lawyer in New York had handily completed the New York Times' Saturday crossword puzzle "“ the hardest of the week "“ for years. But one Saturday morning, suddenly he couldn't retrieve the words to fill in the squares. In Chicago, an 83-year-old woman began parroting the same phrases over and over. When her doctor asked her how she was, she replied, "I am fine. I am fine. I am fine." The symptoms of the New York lawyer and the Chicago woman could have been...

2009-05-15 06:00:00

Cimzia(R) (certolizumab pegol) now offered in an innovative prefilled syringe designed in partnership with OXO GOOD GRIPS(R) ATLANTA, May 15 /PRNewswire/ --- UCB today announced that Cimzia(R) (certolizumab pegol), the only PEGylated anti-TNF (Tumor Necrosis Factor) approved in the U.S. for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderate to severe active disease who have had an inadequate response to conventional therapy, is...

2009-05-13 21:48:00

- Available this week, Cimzia(R) (certolizumab pegol), the only pegylated anti-TNF, offers a new treatment option for U.S. adult patients suffering from moderately to severely active rheumatoid arthritis - Patients treated with Cimzia(R), together with methotrexate, experienced rapid and significant improvements in signs and symptoms, physical function and pain as early as week one, and sustained at week 24 and for up to one year - Patients treated with Cimzia(R) as a monotherapy...

2009-03-03 10:36:40

Multiple sclerosis patients may benefit from the drug fampridine. In a new study conducted in centers in the U.S. and Canada, those who received the drug were able to walk faster on standard tests than those who received a placebo for comparison purposes. Leg strength improved more significantly in people taking the active drug as well. The findings held true across a range of MS disease course types. "Treatment with fampridine produces clinically meaningful improvement in walking ability in...

2009-02-18 14:46:00

Aurora St. Luke's Medical Center Discovers Way to Fight Rare, but Deadly, Side Effect from Drug. MILWAUKEE, Feb. 18 /PRNewswire/ -- Researchers at Aurora St. Luke's Medical Center have developed a technique that counteracts an unusual, but serious, side effect from natalizumab (Tysabri(R)), a drug that fights multiple sclerosis (MS). The side effect is a brain virus called progressive multifocal leukoencephalopathy (PML). "This virus looks like a multiple sclerosis relapse," Dr. Bhupendra...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.